ALK and Ewing sarcoma: Finally, ALK Mutations have been described in 10.4% of neuroblastoma samples but not in other pediatric tumors like RMS, Ewing sarcoma, or DSRCT and only occasionally in other solid tumors like CRC [45], [46].